Clinical Trials · NCT00309478
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Enrollment
- 1,099
- Start date
- Dec 1990
- Locations
- See registry
- Primary endpoint
- Disease-free survival